Optimizing Precision of Hypertension Care to Maximize Blood Pressure Control: A Pilot Study Utilizing a Smartphone App to Incorporate Plasma Renin Activity Testing

Only half of patients with hypertension (HTN) respond to any given antihypertensive medication. Heterogeneity in pathophysiologic pathways underlying HTN is a major contributor. Personalizing antihypertensive therapy could improve blood pressure (BP) reduction. The objective of this study was to ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehanna, Mai, Chen, Yiqing E., Gong, Yan, Handberg, Eileen, Roth, Brittney, De Leon, Jessica, Smith, Steven M., Harrell, Jonathan G., Cooper‐DeHoff, Rhonda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993275/
https://www.ncbi.nlm.nih.gov/pubmed/33142006
http://dx.doi.org/10.1111/cts.12922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993275/
https://www.ncbi.nlm.nih.gov/pubmed/33142006
http://dx.doi.org/10.1111/cts.12922

Ejemplares similares